Back to Agendas
Session 3 Part 1: Plenary - Leveraging activities between regulatory agencies / bodies; Room BC12
Session Chair(s)
Vincent I. Ahonkhai, MD, FAAFP
Senior Advisor, Global Health
Bill & Melinda Gates Foundation, United States
This session will provide participants with an opportunity to get an update from regulatory agencies on the African Medicines Regulatory Harmonization (AMRH) programme. Key implementation learning amongst agencies and within the industry shall be shared in the 1st part of the session.
Speaker(s)
Update on the African Medicines Regulatory Harmonization (AMRH) programme
Samvel Azatyan, MD, PhD
World Health Organization (WHO), Switzerland
Team Lead, Regulatory Convergence and Networks (RCN/REG)
Regulatory Actions to improve access to medicines
Mauricio Cantú González
The Federal Commission for the Protection against Sanitary Risk (COFEPRIS), Mexico
Leveraging activities between regulatory agencies – the Swissmedic approach
Petra Doerr, PharmD, RPh
European Directorate for the Quality of Medicines and Healthcare (EDQM), France
Director
Medicines Harmonisation in Africa Industry perspective case of Kenya
William Mwatu
Kenya Association of the Pharmaceutical Industry (KAPI), Kenya
Chairman
Have an account?
Ways to register
Registration fee includes conference delegate material, refreshments and lunches.
Registration fee can be settled via bank transfer or by Visa and MasterCard credit cards.